| TOC |
| 1. Introducción |
| 1.1. Descripción del informe |
| 1.2. Panorama general del mercado de software farmacéutico de gestión de relaciones con los clientes: Definición |
| 1.3. Ámbito de investigación del mercado |
| 1.4. Mercado cubierto: alcance regional |
| 1.5. Años examinados para el estudio |
| 2. Metodología de investigación |
| 2.1. Descripción |
| 2.1.1 Proceso de investigación de mercados |
| 2.1.2 Adquisiciones de información |
| 2.1.3 Análisis de datos |
| 2.1.4 Formulación de mercado " Validación |
| 3. Resumen |
| 3.1. Principales perspectivas del estudio |
| 3.2. Perspectivas de segmentación por componente |
| 3.3. Perspectivas de segmentación mediante despliegue |
| 3.4. Perspectivas de segmentación por función |
| 3.5. Perspectivas de segmentación por usuario final |
| 3.6. Perspectivas de segmentación por aplicación |
| 3.7 Perspectivas de Segmentación por Región |
| 4. Mercado de Software de gestión de relaciones con clientes – Situación de la industria |
| 4.1 Impacto del COVID-19 en el mercado |
| 4.2. Análisis de la atracción del mercado |
| 4.2.1 Análisis de la atracción del mercado por componente |
| 4.2.2 Análisis de la atracción de mercado por región |
| 4.3. Análisis de la industria |
| 4.3.1 Fuerza |
| 4.3.2 Debilidad |
| 4.3.3 Oportunidades |
| 4.3.4. Amenazas |
| 4.4. Análisis de cinco fuerzas de Porter |
| 4.4.1. Amenaza de nuevos participantes |
| 4.4.2. Poder de negociación de proveedores |
| 4.4.3. Poder de negociación de compradores |
| 4.4.4. Amenaza de los Sustitutos |
| 4.4.5. Rivalry Industry |
| 4.5. Pointers Covered at the Micro Level |
| 4.5.1. Clientes |
| 4.5.2 El lado de la oferta y la demanda |
| 4.5.3 Accionistas e Inversores |
| 4.5.4 Medios de comunicación, publicidad y comercialización |
| 4.6. Puntos cubiertos en el nivel Macro |
| 4.6.1 Factores económicos |
| 4.6.2. Adelantos tecnológicos |
| 4.6.3. Medio ambiente normativo |
| 4.6.4. Tendencias sociales y culturales |
| 4.7. Cadena de valor |
| 4.7.1. Conservación de materias primas |
| 4.7.2. Fabricación/Procesamiento |
| 4.7.3 Control y Prueba de Calidad |
| 4.7.4 Embalaje y distribución |
| Segmento de uso final 4S |
| 4.8. Impacto de la IA en las economías líderes |
| 5. Vista general del mercado y dinámicas clave |
| 5.1. Dinámica del mercado |
| 5.2. Conductores |
| 5.2.1. Conductor 1 |
| 5.2.2. Conductor 2 |
| 5.3 Restricciones y desafíos |
| 5.3.1 Restricciones y desafíos 1 |
| 5.3.2 Restricciones y desafíos 2 |
| 5.4 Oportunidades |
| 5.4.1. Oportunidad 1 |
| 5.4.2. Oportunidad 2 |
| 6. Mercado de Software de gestión de relaciones con clientes Insights and Forecast Analysis |
| 6.1. Mercado de Software de Gestión de Relaciones con clientes farmacéuticosAnalysis y Pronóstico |
| 7. Mercado de Software de gestión de relaciones con clientes Análisis de pronóstico, por componente – 2021 a 2033 |
| 7.1. Mercado de Software de gestión de relaciones con clientes farmacéuticosAnalysis and Forecast, By Component |
| 7.1.1. Software |
| 7.1.2 Servicios |
| 7.1.3. Consulta |
| 7.1.4 Aplicación |
| 7.1.5 Integración |
|
| 8. Mercado de Software de gestión de relaciones con clientes Insights " Forecast Analysis, By Deployment – 2021 to 2033 |
| 8.1. Mercado de Software de gestión de relaciones con clientes farmacéuticosAnalysis and Forecast, By Deployment |
| 8.1.1 Base en la nube |
| 8.1.2. Presencia |
| 8.1.3 híbrido |
| 8.1.4 SaaS |
| 8.1.5 Nube Privada |
|
| 9. Mercado de Software de gestión de relaciones con clientes Análisis de pronóstico, por función – 2021 a 2033 |
| 9.1 Mercado de Software de gestión de relaciones con clientes farmacéuticosAnalysis y Predicción, por Función |
| 9.1.1. Automatización de la fuerza de ventas |
| 9.1.2. Marketing Automation |
| 9.1.3. Servicio al Cliente |
| 9.1.4. Análisis |
| 9.1.5 Gestión de contactos |
|
| 10. Mercado de Software de gestión de relaciones con clientes Análisis de pronóstico, por usuario final – 2021 a 2033 |
| 10.1 Mercado de Software de gestión de relaciones con clientes farmacéuticosAnalysis and Forecast, By End User |
| 10.1.1. Empresas farmacéuticas |
| 10.1.2. Empresas biotecnológicas |
| 10.1.3. |
| 10.1.4. Empresas de dispositivos médicos |
| 10.1.5. Distribuidores |
|
| 11. Mercado de Software de gestión de relaciones con clientes Insights & Forecast Analysis, By Application – 2021 to 2033 |
| 11.1 Mercado de Software de gestión de relaciones con clientes farmacéuticosAnalysis and Forecast, By Application |
| 11.1.1. HCP Engagement |
| 11.1.2 Participación del paciente |
| 11.1.3. Gestión de ventas |
| 11.1.4. Gestión de la Fuerza Móvil |
| 11.1.5. Omnichannel Marketing |
|
| 12 Mercado de Software de gestión de relaciones con clientes Insights " Forecast Analysis, By Region – 2021 to 2033 |
| 12.1 Mercado de software farmacéutico de gestión de relaciones con los clientes, por región |
| 12.2 North America Pharmaceutical Customer Relationship Management Software Market, By Component |
| 12.2.1 North America Pharmaceutical Customer Relationship Management Software Market, By Component, Revenue (USD Billion), (2021 -2033), CAGR (%) (2026-2033) |
| 12.3 North America Pharmaceutical Customer Relationship Management Software Market, By Deployment |
| 12.3.1 North America Pharmaceutical Customer Relationship Management Software Market, By Deployment, Revenue (USD Billion), (2021 -2033), CAGR (%) (2026-2033) |
| 12.4 North America Pharmaceutical Customer Relationship Management Software Market, By Function |
| 12.4.1 North America Pharmaceutical Customer Relationship Management Software Market, By Function, Revenue (USD Billion), (2021 -2033), CAGR (%) (2026-2033) |
| 12.5 North America Pharmaceutical Customer Relationship Management Software Market, By End User |
| 12.5.1 North America Pharmaceutical Customer Relationship Management Software Market, By End User, Revenue (USD Billion), (2021 -2033), CAGR (%) (2026-2033) |
| 12.6 North America Pharmaceutical Customer Relationship Management Software Market, By Application |
| 12.6.1 North America Pharmaceutical Customer Relationship Management Software Market, By Application, Revenue (USD Billion), (2021 -2033), CAGR (%) (2026-2033) |
| 12.7 North America Mercado de Software de Gestión de Relaciones con clientes Insights " Forecast Analysis, BY Segmentation and Country – 2021 - 2033 |
| 12.8 North America Pharmaceutical Customer Relationship Management Software Market, By Country |
| 12.8.1 Estados Unidos |
| 12.8.2 Canadá |
| 12.8.3 México |
| 12.9 Europe Pharmaceutical Customer Relationship Management Software Market, By Component |
| 12.9.1 Europe Pharmaceutical Customer Relationship Management Software Market, By Component, Revenue (USD Billion), (2021 -2033), CAGR (%) (2026-2033) |
| 12.10 Europe Pharmaceutical Customer Relationship Management Software Market, By Deployment |
| 12.10.1 Europe Pharmaceutical Customer Relationship Management Software Market, By Deployment, Revenue (USD Billion), (2021 -2033), CAGR (%) (2026-2033) |
| 12.11 Europe Pharmaceutical Customer Relationship Management Software Market, By Function |
| 12.11.1 Europe Pharmaceutical Customer Relationship Management Software Market, By Function, Revenue (USD Billion), (2021 -2033), CAGR (%) (2026-2033) |
| 12.12 Europe Pharmaceutical Customer Relationship Management Software Market, By End User |
| 12.12.1 Europe Pharmaceutical Customer Relationship Management Software Market, By End User, Revenue (USD Billion), (2021 -2033), CAGR (%) (2026-2033) |
| 12.13 Europe Pharmaceutical Customer Relationship Management Software Market, By Application |
| 12.13.1 Europe Pharmaceutical Customer Relationship Management Software Market, By Application, Revenue (USD Billion), (2021 -2033), CAGR (%) (2026-2033) |
| 12.14 Europa Mercado de Software de Gestión de Relaciones con clientes Insights " Forecast Analysis, BY Segmentation and Country – 2021 - 2033 |
| 12.15 Europe Pharmaceutical Customer Relationship Management Software Market, By Country |
| 12.15.1 Alemania |
| 12.15.2 Reino Unido |
| 12.15.3 Francia |
| 12.15.4 Italia |
| 12.15.5 España |
| 12.15.6 El resto de Europa |
| 12.16 Asia Pacific Pharmaceutical Customer Relationship Management Software Market, By Component |
| 12.16.1 Asia Pacific Pharmaceutical Customer Relationship Management Software Market, By Component, Revenue (USD Billion), (2021 -2033), CAGR (%) (2026-2033) |
| 12.17 Asia Pacific Pharmaceutical Customer Relationship Management Software Market, By Deployment |
| 12.17.1 Asia Pacific Pharmaceutical Customer Relationship Management Software Market, By Deployment, Revenue (USD Billion), (2021 -2033), CAGR (%) (2026-2033) |
| 12.18 Asia Pacific Pharmaceutical Customer Relationship Management Software Market, By Function |
| 12.18.1 Asia Pacific Pharmaceutical Customer Relationship Management Software Market, By Function, Revenue (USD Billion), (2021 -2033), CAGR (%) (2026-2033) |
| 12.19 Asia Pacific Pharmaceutical Customer Relationship Management Software Market, By End User |
| 12.19.1 Asia Pacific Pharmaceutical Customer Relationship Management Software Market, By End User, Revenue (USD Billion), (2021 -2033), CAGR (%) (2026-2033) |
| 12.20 Asia Pacific Pharmaceutical Customer Relationship Management Software Market, By Application |
| 12.20.1 Asia Pacific Pharmaceutical Customer Relationship Management Software Market, By Application, Revenue (USD Billion), (2021 -2033), CAGR (%) (2026-2033) |
| 12.21 Asia Pacific Mercado de Software de gestión de relaciones con clientes Insights " Forecast Analysis, BY Segmentation and Country – 2021 - 2033 |
| 12.22 Asia Pacific Pharmaceutical Customer Relationship Management Software Market, By Country |
| 12.22.1 China |
| 12.22.2 India |
| 12.22.3 Japón |
| 12.22.4 Australia |
| 12.22.5 Corea del Sur |
| 12.22.6 El resto de Asia |
| 12.23 South America Pharmaceutical Customer Relationship Management Software Market, By Component |
| 12.23.1 South America Pharmaceutical Customer Relationship Management Software Market, By Component, Revenue (USD Billion), (2021 -2033), CAGR (%) (2026-2033) |
| 12.24 South America Pharmaceutical Customer Relationship Management Software Market, By Deployment |
| 12.24.1 South America Pharmaceutical Customer Relationship Management Software Market, By Deployment, Revenue (USD Billion), (2021 -2033), CAGR (%) (2026-2033) |
| 12.25 South America Pharmaceutical Customer Relationship Management Software Market, By Function |
| 12.25.1 South America Pharmaceutical Customer Relationship Management Software Market, By Function, Revenue (USD Billion), (2021 -2033), CAGR (%) (2026-2033) |
| 12.26 South America Pharmaceutical Customer Relationship Management Software Market, By End User |
| 12.26.1 South America Pharmaceutical Customer Relationship Management Software Market, By End User, Revenue (USD Billion), (2021 -2033), CAGR (%) (2026-2033) |
| 12.27 South America Pharmaceutical Customer Relationship Management Software Market, By Application |
| 12.27.1 South America Pharmaceutical Customer Relationship Management Software Market, By Application, Revenue (USD Billion), (2721 -2733), CAGR (%) (2726-2733) |
| 12.28 South America Mercado de Software de Gestión de Relaciones con clientes Insights " Forecast Analysis, BY Segmentation and Country – 2021 - 2033 |
| 12.29 South America Pharmaceutical Customer Relationship Management Software Market, By Country |
| 12.29.1 Brasil |
| 12.29.2 Argentina |
| 12.29.3 El resto de América del Sur |
| 12.30 Medio Oriente y África Pharmaceutical Customer Relationship Management Software Market, By Component |
| 12.30.1 Middle East and Africa Pharmaceutical Customer Relationship Management Software Market, By Deployment, Revenue (USD Billion), (2021 -2033), CAGR (%) (2026-2033) |
| 12.31 Medio Oriente y África Pharmaceutical Customer Relationship Management Software Market, Por Despliegue |
| 12.31.1 Middle East and Africa Pharmaceutical Customer Relationship Management Software Market, By Deployment, Revenue (USD Billion), (2021 -2033), CAGR (%) (2026-2033) |
| 12.32 Medio Oriente y África Pharmaceutical Customer Relationship Management Software Market, By Function |
| 12.32.1 Middle East and Africa Pharmaceutical Customer Relationship Management Software Market, By Function, Revenue (USD Billion), (2021 -2033), CAGR (%) (2026-2033) |
| 12.33 Medio Oriente y África Pharmaceutical Customer Relationship Management Software Market, By End User |
| 12.33.1 Middle East and Africa Pharmaceutical Customer Relationship Management Software Market, By End User, Revenue (USD Billion), (2021 -2033), CAGR (%) (2026-2033) |
| 12.34 Medio Oriente y África Pharmaceutical Customer Relationship Management Software Market, por aplicación |
| 12.34.1 Middle East and Africa Pharmaceutical Customer Relationship Management Software Market, By Application, Revenue (USD Billion), (2721 -2733), CAGR (%) (2726-2733) |
| 12.35 Medio Oriente y África Mercado de Software de gestión de relaciones con clientes Insights " Forecast Analysis, BY Segmentation and Country – 2021 - 2033 |
| 12.36 Medio Oriente y África Pharmaceutical Customer Relationship Management Software Market, Por País |
| 12.36.1 Arabia Saudita |
| 12.36.2 Emiratos Árabes Unidos |
| 12.36.3 Sudáfrica |
| 12.36.4 El resto del Oriente Medio y África |
| 13 Pharmaceutical Customer Relationship Management Software Market: Competitive Landscape |
| 13.1 División y Rivalería Competitiva |
| 13.2 Mercado de empresas Análisis de acciones |
| 13.3 Mercado de Software de Gestión de Relación con los Clientes Farmacéuticos: Principales Estrategias de Ganancia |
| 13.4 Mercado de Software de Gestión de Relaciones con los Clientes Farmacéuticos: Análisis Competitivo de Heatmap |
| 14 Pharmaceutical Customer Relationship Management Software Market: Company Profiles |
| 14.1 Veeva Systems |
| 14.1.1 Panorama general de las empresas |
| 14.1.2 Economía Performance of the Company |
| 14.1.3 Principales ejecutivos |
| 14.1.4 Cartera de Productos |
| 14.1.5 Mapping de la estrategia de la empresa |
| 14.2 Salesforce |
| 14.3 Microsoft |
| 14.4 IQVIA |
| 14.5 Oracle |
| 14.6 SAP |
| 14.7 ZS Associates |
| 14.8 Pitcher AG |
| 14.9 Aktana |
| 14.10 Salesforce Life Sciences |
| 14.11 Cegedim |
| 14.12 Indegene |
| 14.13 Pegasystems |
| 14.14 Creatio |
| 14.15 Servicios Ahora |